Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Haemophilus influenzae type B (Hib)-/difteri-/tetanus-/kighostevaccine hætteglas + fyldt sprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
3 |
Haemophilus influenzae type B (Hib)- + difteri- + tetanus- + kighostevaccine i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
4 |
Haemophilus influenzae type b (Hib)-/difteri-/tetanus-/kighostevaccine hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
4 |
difteri- og tetanustoxoider og helcellekighostevaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
|
difteri- og tetanustoxoider og acellulær kighostevaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
|
Diphtheria and tetanus toxoids with pertussis, combined vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
|
kighostevaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
Pertussis vaccine ampules 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
|
Diphtheria toxoid adsorbed ns/pertussis adsorbed ns/tetanus toxoid adsorbed ns injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
|
Administration of vaccine product containing only acellular Bordetella pertussis and Corynebacterium diphtheriae and Hepatitis B virus and inactivated whole Human poliovirus antigens (procedure) |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
difteri-, acellulær kighoste-, hepatitis B- og inaktiveret poliovaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
2 |
adsorberet difteri- + tetanus- + kighostevaccine injektionsvæske, hætteglas a 7,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
|
adsorberet difteri- + tetanus- + kighostevaccine injektionsvæske, hætteglas a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
|
Pertussis vaccine ampules 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
|
difteri- + kighoste- + tetanus- + Haemophilus influenzae type b-vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
3 |
difteri- + tetanus- + kighoste- + poliovaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
3 |
difteri- + tetanus- + kighoste- + inaktiveret poliovirusvaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
difteri-/tetanus-/kighoste-/inaktiveret poliovaccine, i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
|
difteri- + tetanus- + kighoste- + polio- + Haemophilus influenzae type b-vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
difteri-/tetanus-/kighoste-/polio-/Haemophilus influenzae type B-vaccine hætteglas a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
|
lavdosis difteri-/tetanus-/kighoste-/inaktiveret poliovaccine, i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
|
højdosisdifteri-/tetanus-/kighoste-/inaktiveret poliovaccine, i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
|
tetanustoxoid + reduceret difteritoxoid + acellulær kighostevaccine injektionsvæske, hætteglas a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
|
Administration of first dose of pertussis vaccine |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
Administration of second dose of pertussis vaccine |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
Administration of third dose of pertussis vaccine |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
vaccination mod difteri, kighoste, stivkrampe og polio |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
1. vaccination mod difteri, kighoste, stivkrampe og polio |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
2. vaccination mod difteri, kighoste, stivkrampe og polio |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
3. vaccination mod difteri, kighoste, stivkrampe og polio |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
[X]Pertussis vaccine, including combinations with a pertussis component, causing adverse effects in therapeutic use |
Causative agent |
False |
kighostevaccine |
Inferred relationship |
Some |
|
Adverse reaction to diphtheria, pertussis, and tetanus vaccine |
Causative agent |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
Adverse reaction to pertussis vaccine |
Causative agent |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
Allergy to diphtheria and pertussis and tetanus vaccine |
Causative agent |
False |
kighostevaccine |
Inferred relationship |
Some |
|
Allergy to pertussis vaccine |
Causative agent |
False |
kighostevaccine |
Inferred relationship |
Some |
|
Administration of booster dose of pertussis vaccine |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
Administration of vaccine product containing only acellular Bordetella pertussis five component and Clostridium tetani and low dose Corynebacterium diphtheriae and inactivated whole Human poliovirus antigens (procedure) |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
Administration of pertussis vaccine |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
reaktion på kighostevaccine |
Causative agent |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
Administration of first dose of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
Administration of second dose of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
Administration of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
Administration of fourth dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
kighostevaccination, ikke nærmere specificeret |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
vaccination mod difteri, kighoste, stivkrampe og polio, ikke nærmere specificeret |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
Administration of first dose of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens (procedure) |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
Administration of second dose of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens (procedure) |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
Administration of third dose of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens (procedure) |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
Administration of booster dose of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens (procedure) |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
difteri- + kighoste- + tetanusvaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
2 |
forgiftning med kighostevaccine |
Causative agent |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
forgiftning med kighostevaccine inklusive kombinationer med en kighostekomponent |
Causative agent |
False |
kighostevaccine |
Inferred relationship |
Some |
|
difteritoxoid 30 IE + tetanustoxoid 40 IE + acellulært kighostetoxoid 25 µg inaktiveret poliovaccine, i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
|
rekombinant hepatitis B-virusoverfladeantigenvaccine 10 µg + difteritoxoid 30 IE + tetanustoxoid 40 IE + acellulær kighostevaccine 25 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
|
difteritoxoid 30 IE/tetanustoxoid 40 IE/acellulær kighostetoxoid 25 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
|
difteritoxoid 30 IE + tetanustoxoid 40 IE + acellulær kighoste-vaccine 25 µg + rekombinant hepatitis B-virusoverfladeantigen 10 µg + inaktiveret poliovaccine injektionsvæske, opløsning 0,5 ml i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
|
Haemophilus influenzae type b-vaccine 10 µg + difteritoxoid 30 IE + tetanustoxoid 40 IE + kighostevaccine 25 µg + rekombinant hepatitis B-virusoverfladeantigenvaccine 10 µg + inaktiveret poliovaccine injektionsvæske, opløsning 0,5 ml i fyldt sprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
|
difteri- + tetanus- + kighoste- + rekombinant hepatitis B-virus-vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
difteri- + tetanus- + kighoste- + polio- + rekombinant hepatitis B-virus-vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
difteri- + tetanus- + kighoste- + polio- + rekombinant hepatitis B-virus- + rekombinant Haemophilus influenzae type b-vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
vaccination mod difteri, kighoste, stivkrampe og polio |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
Administration of third dose of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens (procedure) |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
vaccination mod difteri, kighoste, stivkrampe og polio, ikke nærmere specificeret |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
2. vaccination mod difteri, kighoste, stivkrampe og polio |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
3. vaccination mod difteri, kighoste, stivkrampe og polio |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
1. vaccination mod difteri, kighoste, stivkrampe og polio |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
Administration of vaccine product containing only acellular Bordetella pertussis five component and Clostridium tetani and low dose Corynebacterium diphtheriae and inactivated whole Human poliovirus antigens (procedure) |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
Administration of first dose of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens (procedure) |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
Administration of booster dose of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens (procedure) |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
Administration of second dose of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens (procedure) |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
3. vaccination mod difteri, kighoste, stivkrampe og polio |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
3 |
vaccination mod difteri, kighoste, stivkrampe og polio |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
3 |
Administration of first dose of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens (procedure) |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
3 |
Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
4 |
Administration of first dose of pertussis vaccine |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
Administration of first dose of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens (procedure) |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
2 |
Administration of third dose of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens (procedure) |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
2 |
Administration of third dose of pertussis vaccine |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
Administration of third dose of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens (procedure) |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
3 |
kighostevaccination, ikke nærmere specificeret |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
Administration of booster dose of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens (procedure) |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
3 |
2. vaccination mod difteri, kighoste og stivkrampe |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
2 |
1. vaccination mod difteri, kighoste og stivkrampe |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
2 |
Administration of vaccine product containing only acellular Bordetella pertussis five component and Clostridium tetani and low dose Corynebacterium diphtheriae and inactivated whole Human poliovirus antigens (procedure) |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
3 |
Administration of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
4 |
vaccination mod difteri, kighoste, stivkrampe og polio, ikke nærmere specificeret |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
3 |
Administration of second dose of pertussis vaccine |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
1. vaccination mod difteri, kighoste, stivkrampe og polio |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
3 |
Administration of booster dose of pertussis vaccine |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
3. vaccination mod difteri, kighoste og stivkrampe |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
2 |
vaccination mod difteri, kighoste og stivkrampe, ikke nærmere specificeret |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
2 |
2. vaccination mod difteri, kighoste, stivkrampe og polio |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
3 |
Administration of second dose of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens (procedure) |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
2 |
Administration of second dose of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens (procedure) |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
3 |
Administration of booster dose of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens (procedure) |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
2 |
Administration of diphtheria, pertussis, and tetanus vaccine |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
2 |
Administration of pertussis vaccine |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
Administration of vaccine product containing only acellular Bordetella pertussis and Corynebacterium diphtheriae and Hepatitis B virus and inactivated whole Human poliovirus antigens (procedure) |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
1 |
Administration of fourth dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
4 |
Administration of first dose of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine |
Direct substance |
False |
kighostevaccine |
Inferred relationship |
Some |
4 |